Neurocrine Biosciences, Inc. - Common Stock — Financial Statistics (NASDAQ:NBIX) | MetaTrader

Open full chart

News

NBIX vs. TEVA: Which Drugmaker Is the Better Investment?

Neurocrine Biosciences Stock: 'House Full Of Options' (NASDAQ:NBIX)

Neurocrine's Ingrezza Sales Keep Growing: Can the Momentum Last?

Can NBIX's Q2 Beat and Higher Ingrezza Guidance Drive More Growth?

Is NBIX Stock a Buy as Fast Growth Meets a Premium Sales Valuation?

Jim Cramer Says Buy Uber, Calls Rockwell Automation 'One Ugly Chart' but a 'Great Long-Term Situation' -

NBIX Stock Dips 12% in a Month: Time to Buy, Hold or Sell?

AMRX Stock Surges 44.8% in 3 Months: Can the Rally Keep Running Now?

XENE's Q2 Loss Narrower Than Expected, Sales Nil, Pipeline in Focus

Krystal Q2 Earnings & Sales Beat Estimates, Pipeline in Focus

Banking Giant JPMorgan Leads 19 Newcomers To IBD Best Stock Lists

AGIO Q2 Earnings Beat Estimates, Revenues Increase Year Over Year